S2Medical AB (publ) (STO:S2M)

Market Cap	10.64M
Revenue (ttm)	14.68M
Net Income (ttm)	4.81M
Shares Out	844.26M
EPS (ttm)	0.01
PE Ratio	1.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,924,815
Average Volume	2,690,501
Open	0.0136
Previous Close	0.0129
Day's Range	0.0123 - 0.0136
52-Week Range	0.0055 - 0.0470
Beta	2.14
RSI	38.79
Earnings Date	Aug 21, 2025

About Nevro

S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2013
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: S2M